Affiliation:
1. Sechenov First Moscow State Medical University (Sechenov University)
Abstract
Introduction. The gradual progression of liver cirrhosis with the development of complications has a negative impact on the life quality of patients with this disease. Modern therapeutic strategies are aimed not only at disease compensating, but much attention is paid to improving the quality of life. No data exists on the effect of serum albumin levels, their structural and functional activity, on the quality of life of patients with cirrhosis. Aim. To evaluate the relationship between serum albumin concentration, its structural configuration (DR), functional properties (BE, RTQ, DTE) and life quality in patients with decompensated liver cirrhosis. Materials and methods. The severity of the structural and functional properties of albumin was evaluated in decompensated patients (n = 50) using electron paramagnetic resonance spectroscopy (EPR spectroscopy). Patients’ quality of life was examined using a standardised SF-36 questionnaire.Results. Pathological changes in DR were observed in 100% of patients, a decrease in BE – in 90%, a violation of RTQ – in 82% of cases, a decrease in DTE was recorded in 76% of patients. The correlation between the level of serum albumin and indicators of physical functioning (PF), role functioning due to emotional state (RE) was ρ = 0,294. Structural and functional albumin properties were related to low indicators of the physical component of health (p < 0,05). Conclusions. А decline in serum albumin levels, a violation of its conformation and functional properties has a negative impact on the quality of life of patients with decompensated liver cirrhosis.
Reference23 articles.
1. Ivashkin V.T., Maevskaya M.V., Zharkova M.S., Zhigalova S.B., Kitsenko E.A., Manukyan G.V. et al. Clinical Recommendations of the Russian Scientific Liver Society and Russian Gastroenterological Association on Diagnosis and Treatment of Liver Fibrosis, Cirrhosis and Their Complications. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;(6):56–102. (In Russ.) Available at: https://www.gastro-j.ru/jour/article/view/621.
2. Younossi Z.M., Boparai N., McCormick M., Price L.L., Guyatt G. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol. 2001;96(2):579–583. https://doi.org/10.1111/j.1572-0241.2001.03537.x.
3. Marchesini G., Bianchi G., Amodio P., Salerno F., Merli M., Panella C. et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120(1):170–178. https://doi.org/10.1053/gast.2001.21193.
4. Younossi Z.M., Boparai N., Price L.L., Kiwi M.L., McCormick M., Guyatt G. Healthrelated quality of life of patients in chronic liver disease: the impact of type and severity of liver disease. Am J Gastroenterol. 2001;96(7):2199–2205. https://doi.org/10.1111/j.1572-0241.2001.03956.x.
5. Lins L., Carvalho F.M. SF-36 total score as a single measure of health- related quality of life: Scoping review. SAGE Open Medicine. 2016;4:2050312116671725. https://doi.org/10.1177/2050312116671725.